Company Filing History:
2 out of 204 
2 out of 870 
1 out of 1,745 
Years Active: 2021-2024
Title: The Innovative Contributions of Laurent Debarbieux
Introduction: Laurent Debarbieux, based in Paris, France, is a distinguished inventor and researcher notable for his contributions to the field of bacteriophage therapy. With three patents to his name, Debarbieux has made significant strides in the treatment of inflammatory bowel disease, showcasing his commitment to advancing medical science through innovation.
Latest Patents: Laurent Debarbieux's latest patents focus on bacteriophage therapy, providing a groundbreaking pharmaceutical composition that includes at least one bacteriophage strain capable of producing a lytic infection in adherent-invasive strains. This invention aims to treat inflammatory bowel disease effectively. Furthermore, the patent outlines a method for administering the bacteriophage strains to subjects in need, demonstrating not only the therapeutic potential of his work but also the development of new bacteriophage strains for improved treatment options.
Career Highlights: Throughout his career, Laurent Debarbieux has collaborated with prominent organizations such as Ferring B.V. and the Institut Pasteur. His work in these institutions has been instrumental in pushing the boundaries of research in bacteriophage therapy. His innovative spirit and dedication to improving healthcare outcomes are evident in all his endeavors.
Collaborations: In addition to his impressive career, Debarbieux has worked alongside notable colleagues, including Pascal Danglas and Jean-Damien Ricard. These collaborations have helped refine his research and expand the impact of his innovations in the medical field.
Conclusion: Laurent Debarbieux stands out as an influential figure in the world of patent innovation, particularly in the area of bacteriophage therapy. His contributions are not only a testament to his expertise as an inventor but also reflect the potential of innovative solutions to address complex health challenges. With a solid foundation in research and collaboration, Debarbieux continues to pave the way for future advancements in medical treatment.